Drug Trial Radar · NCT03468478
Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation
Last checked: Nov 19, 2026Latest source record: Apr 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,209
Actual
Start
Jun 18, 2017
Primary completion
Mar 18, 2021
Study completion Aug 23, 2021
Sponsor
- Lead sponsor
- Hospital do Rim e HipertensãoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 16, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study was designed to compare 3 immunosuppression regimens: sirolimus and tacrolimus versus everolimus and tacrolimus versus mycophenolate and tacrolimus. The primary outcome is the incidence of cytomegalovirus infection / disease, a relevant medical need in the absence of pharmacological prophylaxis.
Conditions
- Kidney Transplant Infection
Interventions
SirolimusDrug
sirolimus combined to reduced dose of tacrolimus
EverolimusDrug
everolimus combined to reduced dose of tacrolimus
Mycophenolic acidDrug
Control arm: mycophenolate combined to regular tacrolimus
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Cytomegalovirus Infection or DiseaseTime frame: 12 months follow up
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hospital do Rim
São Paulo, São Paulo, Brazil
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.